nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefpodoxime—Asthma—Epirubicin—ovarian cancer	0.000923	0.000923	CcSEcCtD
Cefpodoxime—Back pain—Docetaxel—ovarian cancer	0.000923	0.000923	CcSEcCtD
Cefpodoxime—Dehydration—Doxorubicin—ovarian cancer	0.000919	0.000919	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000919	0.000919	CcSEcCtD
Cefpodoxime—Eosinophilia—Epirubicin—ovarian cancer	0.000914	0.000914	CcSEcCtD
Cefpodoxime—Dry skin—Doxorubicin—ovarian cancer	0.000906	0.000906	CcSEcCtD
Cefpodoxime—Shock—Paclitaxel—ovarian cancer	0.000904	0.000904	CcSEcCtD
Cefpodoxime—Dizziness—Vinorelbine—ovarian cancer	0.000903	0.000903	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000899	0.000899	CcSEcCtD
Cefpodoxime—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.00089	0.00089	CcSEcCtD
Cefpodoxime—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.00089	0.00089	CcSEcCtD
Cefpodoxime—Bronchitis—Epirubicin—ovarian cancer	0.000888	0.000888	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000888	0.000888	CcSEcCtD
Cefpodoxime—Anaemia—Docetaxel—ovarian cancer	0.000882	0.000882	CcSEcCtD
Cefpodoxime—Pancytopenia—Epirubicin—ovarian cancer	0.000877	0.000877	CcSEcCtD
Cefpodoxime—Anorexia—Paclitaxel—ovarian cancer	0.000876	0.000876	CcSEcCtD
Cefpodoxime—Gastritis—Doxorubicin—ovarian cancer	0.000875	0.000875	CcSEcCtD
Cefpodoxime—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000872	0.000872	CcSEcCtD
Cefpodoxime—Vomiting—Vinorelbine—ovarian cancer	0.000868	0.000868	CcSEcCtD
Cefpodoxime—Neutropenia—Epirubicin—ovarian cancer	0.000863	0.000863	CcSEcCtD
Cefpodoxime—Dysuria—Epirubicin—ovarian cancer	0.000863	0.000863	CcSEcCtD
Cefpodoxime—Rash—Vinorelbine—ovarian cancer	0.000861	0.000861	CcSEcCtD
Cefpodoxime—Dermatitis—Vinorelbine—ovarian cancer	0.00086	0.00086	CcSEcCtD
Cefpodoxime—Abdominal distension—Doxorubicin—ovarian cancer	0.00086	0.00086	CcSEcCtD
Cefpodoxime—Hypotension—Paclitaxel—ovarian cancer	0.000858	0.000858	CcSEcCtD
Cefpodoxime—Headache—Vinorelbine—ovarian cancer	0.000855	0.000855	CcSEcCtD
Cefpodoxime—Syncope—Docetaxel—ovarian cancer	0.000855	0.000855	CcSEcCtD
Cefpodoxime—Asthma—Doxorubicin—ovarian cancer	0.000854	0.000854	CcSEcCtD
Cefpodoxime—Leukopenia—Docetaxel—ovarian cancer	0.000854	0.000854	CcSEcCtD
Cefpodoxime—Pollakiuria—Epirubicin—ovarian cancer	0.000853	0.000853	CcSEcCtD
Cefpodoxime—Eosinophilia—Doxorubicin—ovarian cancer	0.000846	0.000846	CcSEcCtD
Cefpodoxime—Palpitations—Docetaxel—ovarian cancer	0.000843	0.000843	CcSEcCtD
Cefpodoxime—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000843	0.000843	CcSEcCtD
Cefpodoxime—Weight increased—Epirubicin—ovarian cancer	0.00084	0.00084	CcSEcCtD
Cefpodoxime—Loss of consciousness—Docetaxel—ovarian cancer	0.000838	0.000838	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000837	0.000837	CcSEcCtD
Cefpodoxime—Hyperglycaemia—Epirubicin—ovarian cancer	0.000833	0.000833	CcSEcCtD
Cefpodoxime—Cough—Docetaxel—ovarian cancer	0.000832	0.000832	CcSEcCtD
Cefpodoxime—Insomnia—Paclitaxel—ovarian cancer	0.000831	0.000831	CcSEcCtD
Cefpodoxime—Pneumonia—Epirubicin—ovarian cancer	0.000828	0.000828	CcSEcCtD
Cefpodoxime—Convulsion—Docetaxel—ovarian cancer	0.000827	0.000827	CcSEcCtD
Cefpodoxime—Paraesthesia—Paclitaxel—ovarian cancer	0.000825	0.000825	CcSEcCtD
Cefpodoxime—Hypertension—Docetaxel—ovarian cancer	0.000824	0.000824	CcSEcCtD
Cefpodoxime—Bronchitis—Doxorubicin—ovarian cancer	0.000822	0.000822	CcSEcCtD
Cefpodoxime—Dyspnoea—Paclitaxel—ovarian cancer	0.000819	0.000819	CcSEcCtD
Cefpodoxime—Somnolence—Paclitaxel—ovarian cancer	0.000817	0.000817	CcSEcCtD
Cefpodoxime—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000816	0.000816	CcSEcCtD
Cefpodoxime—Chest pain—Docetaxel—ovarian cancer	0.000812	0.000812	CcSEcCtD
Cefpodoxime—Myalgia—Docetaxel—ovarian cancer	0.000812	0.000812	CcSEcCtD
Cefpodoxime—Pancytopenia—Doxorubicin—ovarian cancer	0.000811	0.000811	CcSEcCtD
Cefpodoxime—Nausea—Vinorelbine—ovarian cancer	0.000811	0.000811	CcSEcCtD
Cefpodoxime—Renal failure—Epirubicin—ovarian cancer	0.000809	0.000809	CcSEcCtD
Cefpodoxime—Dyspepsia—Paclitaxel—ovarian cancer	0.000809	0.000809	CcSEcCtD
Cefpodoxime—Stomatitis—Epirubicin—ovarian cancer	0.000803	0.000803	CcSEcCtD
Cefpodoxime—Neutropenia—Doxorubicin—ovarian cancer	0.000799	0.000799	CcSEcCtD
Cefpodoxime—Dysuria—Doxorubicin—ovarian cancer	0.000799	0.000799	CcSEcCtD
Cefpodoxime—Decreased appetite—Paclitaxel—ovarian cancer	0.000798	0.000798	CcSEcCtD
Cefpodoxime—Dry mouth—Docetaxel—ovarian cancer	0.000794	0.000794	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000793	0.000793	CcSEcCtD
Cefpodoxime—Fatigue—Paclitaxel—ovarian cancer	0.000792	0.000792	CcSEcCtD
Cefpodoxime—Pollakiuria—Doxorubicin—ovarian cancer	0.000789	0.000789	CcSEcCtD
Cefpodoxime—Constipation—Paclitaxel—ovarian cancer	0.000785	0.000785	CcSEcCtD
Cefpodoxime—Pain—Paclitaxel—ovarian cancer	0.000785	0.000785	CcSEcCtD
Cefpodoxime—Haematuria—Epirubicin—ovarian cancer	0.000785	0.000785	CcSEcCtD
Cefpodoxime—Confusional state—Docetaxel—ovarian cancer	0.000785	0.000785	CcSEcCtD
Cefpodoxime—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.00078	0.00078	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Docetaxel—ovarian cancer	0.000779	0.000779	CcSEcCtD
Cefpodoxime—Weight increased—Doxorubicin—ovarian cancer	0.000778	0.000778	CcSEcCtD
Cefpodoxime—Epistaxis—Epirubicin—ovarian cancer	0.000777	0.000777	CcSEcCtD
Cefpodoxime—Sinusitis—Epirubicin—ovarian cancer	0.000772	0.000772	CcSEcCtD
Cefpodoxime—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000771	0.000771	CcSEcCtD
Cefpodoxime—Agranulocytosis—Epirubicin—ovarian cancer	0.000768	0.000768	CcSEcCtD
Cefpodoxime—Pneumonia—Doxorubicin—ovarian cancer	0.000766	0.000766	CcSEcCtD
Cefpodoxime—Shock—Docetaxel—ovarian cancer	0.000766	0.000766	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Docetaxel—ovarian cancer	0.000762	0.000762	CcSEcCtD
Cefpodoxime—Feeling abnormal—Paclitaxel—ovarian cancer	0.000757	0.000757	CcSEcCtD
Cefpodoxime—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000755	0.000755	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000751	0.000751	CcSEcCtD
Cefpodoxime—Renal failure—Doxorubicin—ovarian cancer	0.000749	0.000749	CcSEcCtD
Cefpodoxime—Haemoglobin—Epirubicin—ovarian cancer	0.000743	0.000743	CcSEcCtD
Cefpodoxime—Stomatitis—Doxorubicin—ovarian cancer	0.000743	0.000743	CcSEcCtD
Cefpodoxime—Anorexia—Docetaxel—ovarian cancer	0.000742	0.000742	CcSEcCtD
Cefpodoxime—Rhinitis—Epirubicin—ovarian cancer	0.000741	0.000741	CcSEcCtD
Cefpodoxime—Haemorrhage—Epirubicin—ovarian cancer	0.000739	0.000739	CcSEcCtD
Cefpodoxime—Urticaria—Paclitaxel—ovarian cancer	0.00073	0.00073	CcSEcCtD
Cefpodoxime—Oedema peripheral—Epirubicin—ovarian cancer	0.000728	0.000728	CcSEcCtD
Cefpodoxime—Hypotension—Docetaxel—ovarian cancer	0.000727	0.000727	CcSEcCtD
Cefpodoxime—Haematuria—Doxorubicin—ovarian cancer	0.000726	0.000726	CcSEcCtD
Cefpodoxime—Abdominal pain—Paclitaxel—ovarian cancer	0.000726	0.000726	CcSEcCtD
Cefpodoxime—Body temperature increased—Paclitaxel—ovarian cancer	0.000726	0.000726	CcSEcCtD
Cefpodoxime—Epistaxis—Doxorubicin—ovarian cancer	0.000719	0.000719	CcSEcCtD
Cefpodoxime—Sinusitis—Doxorubicin—ovarian cancer	0.000715	0.000715	CcSEcCtD
Cefpodoxime—Agranulocytosis—Doxorubicin—ovarian cancer	0.000711	0.000711	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000709	0.000709	CcSEcCtD
Cefpodoxime—Insomnia—Docetaxel—ovarian cancer	0.000704	0.000704	CcSEcCtD
Cefpodoxime—Paraesthesia—Docetaxel—ovarian cancer	0.000699	0.000699	CcSEcCtD
Cefpodoxime—Erythema multiforme—Epirubicin—ovarian cancer	0.000699	0.000699	CcSEcCtD
Cefpodoxime—Dyspnoea—Docetaxel—ovarian cancer	0.000694	0.000694	CcSEcCtD
Cefpodoxime—Somnolence—Docetaxel—ovarian cancer	0.000692	0.000692	CcSEcCtD
Cefpodoxime—Tinnitus—Epirubicin—ovarian cancer	0.000689	0.000689	CcSEcCtD
Cefpodoxime—Haemoglobin—Doxorubicin—ovarian cancer	0.000687	0.000687	CcSEcCtD
Cefpodoxime—Rhinitis—Doxorubicin—ovarian cancer	0.000686	0.000686	CcSEcCtD
Cefpodoxime—Dyspepsia—Docetaxel—ovarian cancer	0.000685	0.000685	CcSEcCtD
Cefpodoxime—Haemorrhage—Doxorubicin—ovarian cancer	0.000684	0.000684	CcSEcCtD
Cefpodoxime—Decreased appetite—Docetaxel—ovarian cancer	0.000677	0.000677	CcSEcCtD
Cefpodoxime—Hypersensitivity—Paclitaxel—ovarian cancer	0.000677	0.000677	CcSEcCtD
Cefpodoxime—Oedema peripheral—Doxorubicin—ovarian cancer	0.000674	0.000674	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000672	0.000672	CcSEcCtD
Cefpodoxime—Fatigue—Docetaxel—ovarian cancer	0.000671	0.000671	CcSEcCtD
Cefpodoxime—Pain—Docetaxel—ovarian cancer	0.000666	0.000666	CcSEcCtD
Cefpodoxime—Constipation—Docetaxel—ovarian cancer	0.000666	0.000666	CcSEcCtD
Cefpodoxime—Chills—Epirubicin—ovarian cancer	0.000663	0.000663	CcSEcCtD
Cefpodoxime—Asthenia—Paclitaxel—ovarian cancer	0.000659	0.000659	CcSEcCtD
Cefpodoxime—Alopecia—Epirubicin—ovarian cancer	0.000653	0.000653	CcSEcCtD
Cefpodoxime—Pruritus—Paclitaxel—ovarian cancer	0.00065	0.00065	CcSEcCtD
Cefpodoxime—Erythema multiforme—Doxorubicin—ovarian cancer	0.000647	0.000647	CcSEcCtD
Cefpodoxime—Feeling abnormal—Docetaxel—ovarian cancer	0.000642	0.000642	CcSEcCtD
Cefpodoxime—Tinnitus—Doxorubicin—ovarian cancer	0.000638	0.000638	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000637	0.000637	CcSEcCtD
Cefpodoxime—Flatulence—Epirubicin—ovarian cancer	0.000634	0.000634	CcSEcCtD
Cefpodoxime—Tension—Epirubicin—ovarian cancer	0.000631	0.000631	CcSEcCtD
Cefpodoxime—Dysgeusia—Epirubicin—ovarian cancer	0.00063	0.00063	CcSEcCtD
Cefpodoxime—Diarrhoea—Paclitaxel—ovarian cancer	0.000628	0.000628	CcSEcCtD
Cefpodoxime—Nervousness—Epirubicin—ovarian cancer	0.000625	0.000625	CcSEcCtD
Cefpodoxime—Back pain—Epirubicin—ovarian cancer	0.000622	0.000622	CcSEcCtD
Cefpodoxime—Body temperature increased—Docetaxel—ovarian cancer	0.000615	0.000615	CcSEcCtD
Cefpodoxime—Abdominal pain—Docetaxel—ovarian cancer	0.000615	0.000615	CcSEcCtD
Cefpodoxime—Chills—Doxorubicin—ovarian cancer	0.000614	0.000614	CcSEcCtD
Cefpodoxime—Dizziness—Paclitaxel—ovarian cancer	0.000607	0.000607	CcSEcCtD
Cefpodoxime—Alopecia—Doxorubicin—ovarian cancer	0.000604	0.000604	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Epirubicin—ovarian cancer	0.000597	0.000597	CcSEcCtD
Cefpodoxime—Anaemia—Epirubicin—ovarian cancer	0.000595	0.000595	CcSEcCtD
Cefpodoxime—Agitation—Epirubicin—ovarian cancer	0.000591	0.000591	CcSEcCtD
Cefpodoxime—Flatulence—Doxorubicin—ovarian cancer	0.000587	0.000587	CcSEcCtD
Cefpodoxime—Tension—Doxorubicin—ovarian cancer	0.000584	0.000584	CcSEcCtD
Cefpodoxime—Vomiting—Paclitaxel—ovarian cancer	0.000584	0.000584	CcSEcCtD
Cefpodoxime—Dysgeusia—Doxorubicin—ovarian cancer	0.000583	0.000583	CcSEcCtD
Cefpodoxime—Malaise—Epirubicin—ovarian cancer	0.00058	0.00058	CcSEcCtD
Cefpodoxime—Rash—Paclitaxel—ovarian cancer	0.000579	0.000579	CcSEcCtD
Cefpodoxime—Dermatitis—Paclitaxel—ovarian cancer	0.000579	0.000579	CcSEcCtD
Cefpodoxime—Nervousness—Doxorubicin—ovarian cancer	0.000578	0.000578	CcSEcCtD
Cefpodoxime—Vertigo—Epirubicin—ovarian cancer	0.000578	0.000578	CcSEcCtD
Cefpodoxime—Syncope—Epirubicin—ovarian cancer	0.000577	0.000577	CcSEcCtD
Cefpodoxime—Leukopenia—Epirubicin—ovarian cancer	0.000576	0.000576	CcSEcCtD
Cefpodoxime—Back pain—Doxorubicin—ovarian cancer	0.000576	0.000576	CcSEcCtD
Cefpodoxime—Headache—Paclitaxel—ovarian cancer	0.000575	0.000575	CcSEcCtD
Cefpodoxime—Hypersensitivity—Docetaxel—ovarian cancer	0.000574	0.000574	CcSEcCtD
Cefpodoxime—Palpitations—Epirubicin—ovarian cancer	0.000569	0.000569	CcSEcCtD
Cefpodoxime—Loss of consciousness—Epirubicin—ovarian cancer	0.000566	0.000566	CcSEcCtD
Cefpodoxime—Cough—Epirubicin—ovarian cancer	0.000561	0.000561	CcSEcCtD
Cefpodoxime—Asthenia—Docetaxel—ovarian cancer	0.000559	0.000559	CcSEcCtD
Cefpodoxime—Convulsion—Epirubicin—ovarian cancer	0.000557	0.000557	CcSEcCtD
Cefpodoxime—Hypertension—Epirubicin—ovarian cancer	0.000556	0.000556	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000552	0.000552	CcSEcCtD
Cefpodoxime—Pruritus—Docetaxel—ovarian cancer	0.000551	0.000551	CcSEcCtD
Cefpodoxime—Anaemia—Doxorubicin—ovarian cancer	0.00055	0.00055	CcSEcCtD
Cefpodoxime—Chest pain—Epirubicin—ovarian cancer	0.000548	0.000548	CcSEcCtD
Cefpodoxime—Myalgia—Epirubicin—ovarian cancer	0.000548	0.000548	CcSEcCtD
Cefpodoxime—Agitation—Doxorubicin—ovarian cancer	0.000547	0.000547	CcSEcCtD
Cefpodoxime—Anxiety—Epirubicin—ovarian cancer	0.000546	0.000546	CcSEcCtD
Cefpodoxime—Nausea—Paclitaxel—ovarian cancer	0.000546	0.000546	CcSEcCtD
Cefpodoxime—Discomfort—Epirubicin—ovarian cancer	0.000541	0.000541	CcSEcCtD
Cefpodoxime—Malaise—Doxorubicin—ovarian cancer	0.000537	0.000537	CcSEcCtD
Cefpodoxime—Dry mouth—Epirubicin—ovarian cancer	0.000536	0.000536	CcSEcCtD
Cefpodoxime—Vertigo—Doxorubicin—ovarian cancer	0.000535	0.000535	CcSEcCtD
Cefpodoxime—Syncope—Doxorubicin—ovarian cancer	0.000534	0.000534	CcSEcCtD
Cefpodoxime—Leukopenia—Doxorubicin—ovarian cancer	0.000533	0.000533	CcSEcCtD
Cefpodoxime—Diarrhoea—Docetaxel—ovarian cancer	0.000533	0.000533	CcSEcCtD
Cefpodoxime—Confusional state—Epirubicin—ovarian cancer	0.000529	0.000529	CcSEcCtD
Cefpodoxime—Palpitations—Doxorubicin—ovarian cancer	0.000526	0.000526	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Epirubicin—ovarian cancer	0.000525	0.000525	CcSEcCtD
Cefpodoxime—Loss of consciousness—Doxorubicin—ovarian cancer	0.000523	0.000523	CcSEcCtD
Cefpodoxime—Cough—Doxorubicin—ovarian cancer	0.00052	0.00052	CcSEcCtD
Cefpodoxime—Shock—Epirubicin—ovarian cancer	0.000517	0.000517	CcSEcCtD
Cefpodoxime—Convulsion—Doxorubicin—ovarian cancer	0.000516	0.000516	CcSEcCtD
Cefpodoxime—Dizziness—Docetaxel—ovarian cancer	0.000515	0.000515	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Epirubicin—ovarian cancer	0.000514	0.000514	CcSEcCtD
Cefpodoxime—Hypertension—Doxorubicin—ovarian cancer	0.000514	0.000514	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Epirubicin—ovarian cancer	0.000508	0.000508	CcSEcCtD
Cefpodoxime—Myalgia—Doxorubicin—ovarian cancer	0.000507	0.000507	CcSEcCtD
Cefpodoxime—Chest pain—Doxorubicin—ovarian cancer	0.000507	0.000507	CcSEcCtD
Cefpodoxime—Anxiety—Doxorubicin—ovarian cancer	0.000505	0.000505	CcSEcCtD
Cefpodoxime—Discomfort—Doxorubicin—ovarian cancer	0.000501	0.000501	CcSEcCtD
Cefpodoxime—Anorexia—Epirubicin—ovarian cancer	0.000501	0.000501	CcSEcCtD
Cefpodoxime—Dry mouth—Doxorubicin—ovarian cancer	0.000496	0.000496	CcSEcCtD
Cefpodoxime—Vomiting—Docetaxel—ovarian cancer	0.000495	0.000495	CcSEcCtD
Cefpodoxime—Rash—Docetaxel—ovarian cancer	0.000491	0.000491	CcSEcCtD
Cefpodoxime—Hypotension—Epirubicin—ovarian cancer	0.000491	0.000491	CcSEcCtD
Cefpodoxime—Dermatitis—Docetaxel—ovarian cancer	0.00049	0.00049	CcSEcCtD
Cefpodoxime—Confusional state—Doxorubicin—ovarian cancer	0.00049	0.00049	CcSEcCtD
Cefpodoxime—Headache—Docetaxel—ovarian cancer	0.000488	0.000488	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000486	0.000486	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000478	0.000478	CcSEcCtD
Cefpodoxime—Shock—Doxorubicin—ovarian cancer	0.000478	0.000478	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000476	0.000476	CcSEcCtD
Cefpodoxime—Insomnia—Epirubicin—ovarian cancer	0.000475	0.000475	CcSEcCtD
Cefpodoxime—Paraesthesia—Epirubicin—ovarian cancer	0.000472	0.000472	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00047	0.00047	CcSEcCtD
Cefpodoxime—Dyspnoea—Epirubicin—ovarian cancer	0.000468	0.000468	CcSEcCtD
Cefpodoxime—Somnolence—Epirubicin—ovarian cancer	0.000467	0.000467	CcSEcCtD
Cefpodoxime—Anorexia—Doxorubicin—ovarian cancer	0.000463	0.000463	CcSEcCtD
Cefpodoxime—Nausea—Docetaxel—ovarian cancer	0.000462	0.000462	CcSEcCtD
Cefpodoxime—Dyspepsia—Epirubicin—ovarian cancer	0.000462	0.000462	CcSEcCtD
Cefpodoxime—Decreased appetite—Epirubicin—ovarian cancer	0.000456	0.000456	CcSEcCtD
Cefpodoxime—Hypotension—Doxorubicin—ovarian cancer	0.000454	0.000454	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000453	0.000453	CcSEcCtD
Cefpodoxime—Fatigue—Epirubicin—ovarian cancer	0.000453	0.000453	CcSEcCtD
Cefpodoxime—Constipation—Epirubicin—ovarian cancer	0.000449	0.000449	CcSEcCtD
Cefpodoxime—Pain—Epirubicin—ovarian cancer	0.000449	0.000449	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000443	0.000443	CcSEcCtD
Cefpodoxime—Insomnia—Doxorubicin—ovarian cancer	0.000439	0.000439	CcSEcCtD
Cefpodoxime—Paraesthesia—Doxorubicin—ovarian cancer	0.000436	0.000436	CcSEcCtD
Cefpodoxime—Dyspnoea—Doxorubicin—ovarian cancer	0.000433	0.000433	CcSEcCtD
Cefpodoxime—Feeling abnormal—Epirubicin—ovarian cancer	0.000433	0.000433	CcSEcCtD
Cefpodoxime—Somnolence—Doxorubicin—ovarian cancer	0.000432	0.000432	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000429	0.000429	CcSEcCtD
Cefpodoxime—Dyspepsia—Doxorubicin—ovarian cancer	0.000428	0.000428	CcSEcCtD
Cefpodoxime—Decreased appetite—Doxorubicin—ovarian cancer	0.000422	0.000422	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000419	0.000419	CcSEcCtD
Cefpodoxime—Fatigue—Doxorubicin—ovarian cancer	0.000419	0.000419	CcSEcCtD
Cefpodoxime—Urticaria—Epirubicin—ovarian cancer	0.000417	0.000417	CcSEcCtD
Cefpodoxime—Pain—Doxorubicin—ovarian cancer	0.000415	0.000415	CcSEcCtD
Cefpodoxime—Constipation—Doxorubicin—ovarian cancer	0.000415	0.000415	CcSEcCtD
Cefpodoxime—Abdominal pain—Epirubicin—ovarian cancer	0.000415	0.000415	CcSEcCtD
Cefpodoxime—Body temperature increased—Epirubicin—ovarian cancer	0.000415	0.000415	CcSEcCtD
Cefpodoxime—Feeling abnormal—Doxorubicin—ovarian cancer	0.0004	0.0004	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000397	0.000397	CcSEcCtD
Cefpodoxime—Hypersensitivity—Epirubicin—ovarian cancer	0.000387	0.000387	CcSEcCtD
Cefpodoxime—Urticaria—Doxorubicin—ovarian cancer	0.000386	0.000386	CcSEcCtD
Cefpodoxime—Body temperature increased—Doxorubicin—ovarian cancer	0.000384	0.000384	CcSEcCtD
Cefpodoxime—Abdominal pain—Doxorubicin—ovarian cancer	0.000384	0.000384	CcSEcCtD
Cefpodoxime—Asthenia—Epirubicin—ovarian cancer	0.000377	0.000377	CcSEcCtD
Cefpodoxime—Pruritus—Epirubicin—ovarian cancer	0.000372	0.000372	CcSEcCtD
Cefpodoxime—Diarrhoea—Epirubicin—ovarian cancer	0.000359	0.000359	CcSEcCtD
Cefpodoxime—Hypersensitivity—Doxorubicin—ovarian cancer	0.000358	0.000358	CcSEcCtD
Cefpodoxime—Asthenia—Doxorubicin—ovarian cancer	0.000349	0.000349	CcSEcCtD
Cefpodoxime—Dizziness—Epirubicin—ovarian cancer	0.000347	0.000347	CcSEcCtD
Cefpodoxime—Pruritus—Doxorubicin—ovarian cancer	0.000344	0.000344	CcSEcCtD
Cefpodoxime—Vomiting—Epirubicin—ovarian cancer	0.000334	0.000334	CcSEcCtD
Cefpodoxime—Diarrhoea—Doxorubicin—ovarian cancer	0.000332	0.000332	CcSEcCtD
Cefpodoxime—Rash—Epirubicin—ovarian cancer	0.000331	0.000331	CcSEcCtD
Cefpodoxime—Dermatitis—Epirubicin—ovarian cancer	0.000331	0.000331	CcSEcCtD
Cefpodoxime—Headache—Epirubicin—ovarian cancer	0.000329	0.000329	CcSEcCtD
Cefpodoxime—Dizziness—Doxorubicin—ovarian cancer	0.000321	0.000321	CcSEcCtD
Cefpodoxime—Nausea—Epirubicin—ovarian cancer	0.000312	0.000312	CcSEcCtD
Cefpodoxime—Vomiting—Doxorubicin—ovarian cancer	0.000309	0.000309	CcSEcCtD
Cefpodoxime—Rash—Doxorubicin—ovarian cancer	0.000306	0.000306	CcSEcCtD
Cefpodoxime—Dermatitis—Doxorubicin—ovarian cancer	0.000306	0.000306	CcSEcCtD
Cefpodoxime—Headache—Doxorubicin—ovarian cancer	0.000304	0.000304	CcSEcCtD
Cefpodoxime—Nausea—Doxorubicin—ovarian cancer	0.000289	0.000289	CcSEcCtD
